Analyst Research
| Report Title | Price |
|---|---|
|
Provider: GlobalData
|
$250.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: GlobalData
|
$125.00
|
|
Provider: GlobalData
|
$250.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
KYUNG NAM PHARM.CO.,LTD. Appoints New CEO
KYUNG NAM PHARM.CO.,LTD. announced that it has appointed Oh Chang Hwan as its new Chief Executive Officer, replacing Lee Hui Cheol, effective January 22, 2013.
Latest Developments for Kyung Nam Pharm Co Ltd
Latest Key Developments in Pharmaceuticals
- Wai Yuen Tong Medicine Holdings Ltd Comments On FY 2013 Earnings Guidance
- BioPorto A/S Updates on NGAL Patent Processing of Appeal in Opposition Case
- Astellas Pharma Inc Receives Marketing Authorization for VESOMNI from The Netherlands Medicines Evaluation Board
- Nordion Inc Enters Into Agreement To Divest Targeted Therapies Business To BTG Plc
- Share this
- Link this
- Digg this
Follow Reuters